Validity of the ESSENCE‐Q neurodevelopmental screening tool in Japan
Kahoko Yasumitsu‐Lovell,Lucy Thompson,Elisabeth Fernell,Masamitsu Eitoku,Narufumi Suganuma,Christopher Gillberg,and the Japan Environment and Children's Study Group,Michihiro Kamijima,Shin Yamazaki,Yukihiro Ohya,Reiko Kishi,Nobuo Yaegashi,Koichi Hashimoto,Chisato Mori,Shuichi Ito,Zentaro Yamagata,Hidekuni Inadera,Takeo Nakayama,Tomotaka Sobue,Masayuki Shima,Seiji Kageyama,Narufumi Suganuma,Shoichi Ohga,Takahiko Katoh
DOI: https://doi.org/10.1111/dmcn.15956
2024-05-18
Developmental Medicine & Child Neurology
Abstract:ROC curve for ESSENCE‐Q scores at child age 2.5 years according to NDD diagnosis at 3 years of age Aim To assess the validity of the Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations–Questionnaire (ESSENCE‐Q), a simple screening tool for neurodevelopmental problems, in Japan. Method Parents/caregivers completed the 11‐item ESSENCE‐Q for 77 612 children aged 2 years 6 months included in a national birth cohort study. Information about neurodevelopmental disorders (NDDs: autism spectrum disorder; intellectual disability and/or developmental language disorder; motor delay/motor disorder) was collected at age 3 years. Each ESSENCE‐Q item was scored on a binary (0,1) scale, with a total score range of 0 to 11. Total scores and individual items were compared across children with and without NDDs. Results NDDs were recorded in 854 children (1.1%). With a total ESSENCE‐Q score cut‐off of ≥3, receiver operating characteristic curve analysis showed an area under the curve of 0.91, with sensitivity 84.9%, specificity 84.8%, positive predictive value 5.9%, and negative predictive value 99.8%. The proportion of parental concerns at 2 years 6 months differed significantly by NDD status for communication (89.5% vs 14.2%) and general development (80.2% vs 7.4%). ESSENCE‐Q total scores were moderately negatively correlated (−0.36, p
pediatrics,clinical neurology